News & AnalysisClinical Trials

Europe Debates Ethics Reviews, Data Release

Science  01 Mar 2013:
Vol. 339, Issue 6123, pp. 1024
DOI: 10.1126/science.339.6123.1024

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

European countries are embroiled in a debate over how to redo rules for clinical trials, an effort to replace a controversial 12-year-old directive that critics say bound human research studies in red tape. But preserving stringent patient protections without tipping into excessive bureaucracy—and getting 27 countries to agree—is no easy task.